Sun Pharma introduces Noveltreat & Sematrinity semaglutide in India, offering affordable alternatives for diabetes & weight management....
pharma manufacturing
Indian drugmakers compete for obesity market share as generic weight-loss drugs drive prices down, increasing access but...
Alkem Labs enters India's weight-loss market with Semaglutide injection, offering a cost-effective solution for diabetes and weight...
Indian firms launch generic semaglutide, challenging Novo Nordisk's Ozempic & Wegovy. Affordable access to diabetes & weight...
Dr. Reddy's Laboratories introduces Obeda, a semaglutide injectable, in India, enhancing their diabetes care portfolio. A new...
Dr. Reddy's Laboratories introduces 'Obeda', a semaglutide version for diabetes management in India. Aims to expand its...
Dr. Reddy's introduces Obeda, a generic semaglutide injection, the first DCGI-approved treatment for Type 2 diabetes in...
Novo Nordisk to monitor generic semaglutide entrants in India after patent expiration. Tracking market strategies amid potential...
Generic semaglutide versions are set to dramatically reduce prices in India, boosting access to affordable weight-loss and...
India's PLI scheme for pharmaceuticals doubles its commitment, attracting ₹41,943 crore ($5B) in investments. Boosts domestic pharma...